DalsnaFinance › IPOs › Pasithea Therapeutics › IPO
Pasithea Therapeutics Corp. completed its initial public offering on NASDAQ on September 15, 2021, pricing at $5.00 a share.
| Ticker | KTTA |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | September 15, 2021 |
| Offering price | $5.00 |
| Shares offered | 4,800,000 |
| Total raised | $24M |
Pasithea Therapeutics Corp. sold 4,800,000 shares at $5.00 each on NASDAQ. Multiplied out, that is $24 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $24 million total recorded for the deal.
Pasithea Therapeutics Corp. — quote, profile and latest news →
Source: SEC EDGAR filings for Pasithea Therapeutics Corp.. This page is general information, not investment advice.